Remove 2020 Remove Diabetes Remove Prescription Filling
article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

Similarly, long-acting insulin analogs provide more stable blood sugar control and reduce the number of daily injections needed for diabetes patients. Prior authorization and association with delayed or discontinued prescription fills. Retrieved from [link] ii Office of the Inspector General, U.S. and Keating, N. and Thom, B.

article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

The NHC recognizes that Medicare already covers AOMs for patients who are overweight and have comorbid conditions such as diabetes or cardiovascular disease. 12 Mark Kyle and Natalie Keating, “Prior Authorization and Association with Delayed or Discontinued Prescription Fills,” Journal of Clinical Oncology 42, no.

article thumbnail

Too Much of a Good Thing? Unpacking the Rise of Polypharmacy in Seniors

PharmD Live

However, aging also brings about physiological and pathological changes that increase the risk of developing multiple chronic diseases, such as cardiovascular disease, stroke, and diabetes. “Polypharmacy and Elderly Patients: A 2020 Study,” Journal of Geriatric Care ). Reference: Smith, J. & & Doe, A.